Neonatal Outcomes in Term Infants with Maternal Selective Serotonin Reuptake Inhibitor Use: A Retrospective Chart Review Before, During, and After the COVID-19 Pandemic

Carlie G. Gatlin, Children's Mercy Hospital, Olathe, KS, United States; Megan Tucker, Children's Mercy Hospitals and Clinics, Fairway, KS, United States; Angela M. Bolton, Children's Mercy Hospitals and Clinics, Lenexa, KS, United States; Mary Anne Kucera, Children's Mercy Hospitals and Clinics, prairie village, KS, United States; Deanna McPherson, Children's Mercy Hospitals and Clinics, Lees Summit, MO, United States; Kerry e. Kohrs, Children's Mercy Hospitals and Clinics, Lees Summit, MO, United States; Staci S. Elliott, Children's Mercy Hospitals and Clinics, Overland Park, KS, United States; Hung-Wen Yeh, Children's Mercy Hospitals and Clinics, Kansas City, MO, United States; Venkatesh Sampath, Children's Mercy Kansas City, kansas city, KS, United States